Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
FDA Orange Book
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Beta Subunit Hcg (123-145)
2. Hcg-beta (123-145)
1. Hcg-beta (123-145)
2. Beta-subunit Hcg (123-145)
3. 66053-67-6
4. Beta Subunit Hcg (123-145)
5. L-glutamine, L-alanyl-l-prolyl-l-prolyl-l-prolyl-l-seryl-l-leucyl-l-prolyl-l-seryl-l-prolyl-l-seryl-l-arginyl-l-leucyl-l-prolylglycyl-l-prolyl-l-seryl-l-alpha-aspartyl-l-threonyl-l-prolyl-l-isoleucyl-l-leucyl-l-prolyl-
Molecular Weight | 2321.6 g/mol |
---|---|
Molecular Formula | C105H169N27O32 |
XLogP3 | -8.6 |
Hydrogen Bond Donor Count | 25 |
Hydrogen Bond Acceptor Count | 34 |
Rotatable Bond Count | 59 |
Exact Mass | 2321.2460512 g/mol |
Monoisotopic Mass | 2320.2426963 g/mol |
Topological Polar Surface Area | 868 Ų |
Heavy Atom Count | 164 |
Formal Charge | 0 |
Complexity | 5430 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 24 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3807
Submission : 1980-05-20
Status : Active
Type : II
NDC Package Code : 60870-0315
Start Marketing Date : 1980-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
VMF Number : 5912
Submission : 2007-11-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30237
Submission : 2016-01-16
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-28
Pay. Date : 2013-03-14
DMF Number : 25821
Submission : 2012-02-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3840
Submission : 1980-06-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9356
Submission : 1991-10-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5085
Submission : 1983-08-30
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2262
Submission : 1974-03-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4281
Submission : 1981-09-23
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5626
Submission : 1984-11-27
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Dosage Form : Choriogonadotropin Alfa 250Mcg/0...
Dosage Strength : 1 pen 250 mcg 0.5 ml + 1 needle
Price Per Pack (Euro) : 43.2
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Human Chorionic Gonadotropin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Human Chorionic Gonadotropin, including repackagers and relabelers. The FDA regulates Human Chorionic Gonadotropin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Human Chorionic Gonadotropin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Human Chorionic Gonadotropin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Human Chorionic Gonadotropin supplier is an individual or a company that provides Human Chorionic Gonadotropin active pharmaceutical ingredient (API) or Human Chorionic Gonadotropin finished formulations upon request. The Human Chorionic Gonadotropin suppliers may include Human Chorionic Gonadotropin API manufacturers, exporters, distributors and traders.
click here to find a list of Human Chorionic Gonadotropin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Human Chorionic Gonadotropin DMF (Drug Master File) is a document detailing the whole manufacturing process of Human Chorionic Gonadotropin active pharmaceutical ingredient (API) in detail. Different forms of Human Chorionic Gonadotropin DMFs exist exist since differing nations have different regulations, such as Human Chorionic Gonadotropin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Human Chorionic Gonadotropin DMF submitted to regulatory agencies in the US is known as a USDMF. Human Chorionic Gonadotropin USDMF includes data on Human Chorionic Gonadotropin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Human Chorionic Gonadotropin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Human Chorionic Gonadotropin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Human Chorionic Gonadotropin Drug Master File in Japan (Human Chorionic Gonadotropin JDMF) empowers Human Chorionic Gonadotropin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Human Chorionic Gonadotropin JDMF during the approval evaluation for pharmaceutical products. At the time of Human Chorionic Gonadotropin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Human Chorionic Gonadotropin suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Human Chorionic Gonadotropin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Human Chorionic Gonadotropin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Human Chorionic Gonadotropin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Human Chorionic Gonadotropin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Human Chorionic Gonadotropin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Human Chorionic Gonadotropin suppliers with NDC on PharmaCompass.
Human Chorionic Gonadotropin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Human Chorionic Gonadotropin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Human Chorionic Gonadotropin GMP manufacturer or Human Chorionic Gonadotropin GMP API supplier for your needs.
A Human Chorionic Gonadotropin CoA (Certificate of Analysis) is a formal document that attests to Human Chorionic Gonadotropin's compliance with Human Chorionic Gonadotropin specifications and serves as a tool for batch-level quality control.
Human Chorionic Gonadotropin CoA mostly includes findings from lab analyses of a specific batch. For each Human Chorionic Gonadotropin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Human Chorionic Gonadotropin may be tested according to a variety of international standards, such as European Pharmacopoeia (Human Chorionic Gonadotropin EP), Human Chorionic Gonadotropin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Human Chorionic Gonadotropin USP).
LOOKING FOR A SUPPLIER?